Legal Representation
Attorney
                                            MARGARET M. POWERS
                                        USPTO Deadlines
                                Next Deadline
                            
                            
                                    
                                        
                                        2076 days remaining
                                    
                            
                        Section 8 (6-Year) Declaration Due (Based on registration date 2025-07-08)
                                    
                                    Due Date
                                
                                
                                    July 08, 2031
                                
                            
                                        
                                        Grace Period Ends
                                    
                                    
                                        January 08, 2032
                                    
                                
                            
                            Additional deadlines exist. Contact your attorney for complete deadline information.
                        
                Application History
22 events| Date | Code | Type | Description | Documents | 
|---|---|---|---|---|
| Jul 8, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... | 
| Jul 8, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... | 
| May 20, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... | 
| May 20, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... | 
| May 14, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... | 
| Apr 18, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... | 
| Apr 18, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... | 
| Apr 18, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... | 
| Apr 18, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... | 
| Apr 18, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... | 
| Apr 7, 2025 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... | 
| Apr 3, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... | 
| Apr 3, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... | 
| Apr 3, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... | 
| Apr 3, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... | 
| Apr 3, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... | 
| Mar 18, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... | 
| Mar 18, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... | 
| Mar 18, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... | 
| Mar 18, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... | 
| Mar 17, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... | 
| Sep 5, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... | 
Detailed Classifications
                                                Class 009
                                            
                                        Downloadable computer software for accessing information in the field of medicine and pharmaceutical research and development services; downloadable computer software used to analyse medical research data
                                        
                                                Class 035
                                            
                                        Business consultancy and advisory services; provision of business information and business advisory services to laboratory networks and diagnostic and pharmaceutical companies; compilation of information, statistics and data into databases in the field of medicine and pharmaceutical testing, research and development services; business data analysis; business advisory and consultancy services relating to business intelligence and industry research; compilation of information into computer databases
                                        
                                                Class 042
                                            
                                        Research and development of medicines and pharmaceutical products; research and development in the field of diagnostic preparations; provision of scientific information and data relating to medical and veterinary research and development; technical medical and pharmaceutical data analysis services for research and development purposes for others; providing non-downloadable software as software as a service (SAAS) services featuring software for business data management, data analysis, data manipulation, and medicine and pharmaceutical testing, and accessing information in the field of research and development services; providing non-downloadable software as software as a service (SAAS) services featuring software for business data management and visualisation, for generating reports, charts and dashboards in the field of business information; providing non-downloadable software platform as a service (PAAS) services featuring computer software platforms for business data management, data analysis, data manipulation, and medicine and pharmaceutical testing, and accessing information in the field of research and development services; scientific information, advice and consultancy in relation to all the aforesaid services
                                        Additional Information
                                                
                                                Pseudo Mark
                                            
                                        SIX A
                                    Classification
                                            
                                            International Classes
                                        
                                        
                                                    009
                                                    035
                                                    042